- Home
- FDMT vs DIN Comparison
FDMT vs DIN Comparison
Compare FDMT & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- DIN
- Stock Information
- Founded
- FDMT 2013
- DIN 1958
- Country
- FDMT United States
- DIN United States
- Employees
- FDMT N/A
- DIN N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- DIN Restaurants
- Sector
- FDMT Health Care
- DIN Consumer Discretionary
- Exchange
- FDMT Nasdaq
- DIN Nasdaq
- Market Cap
- FDMT 420.7M
- DIN 462.0M
- IPO Year
- FDMT 2020
- DIN 1991
- Fundamental
- Price
- FDMT $8.24
- DIN $34.77
- Analyst Decision
- FDMT Strong Buy
- DIN Buy
- Analyst Count
- FDMT 9
- DIN 8
- Target Price
- FDMT $46.88
- DIN $42.50
- AVG Volume (30 Days)
- FDMT 660.3K
- DIN 523.0K
- Earning Date
- FDMT 11-15-2024
- DIN 11-06-2024
- Dividend Yield
- FDMT N/A
- DIN 5.79%
- EPS Growth
- FDMT N/A
- DIN 25.15
- EPS
- FDMT N/A
- DIN 6.02
- Revenue
- FDMT $20,218,000.00
- DIN $813,838,000.00
- Revenue This Year
- FDMT N/A
- DIN N/A
- Revenue Next Year
- FDMT $57.85
- DIN $1.11
- P/E Ratio
- FDMT N/A
- DIN $5.85
- Revenue Growth
- FDMT 784.81
- DIN N/A
- 52 Week Low
- FDMT $7.90
- DIN $28.25
- 52 Week High
- FDMT $36.25
- DIN $52.05
- Technical
- Relative Strength Index (RSI)
- FDMT 34.92
- DIN 61.58
- Support Level
- FDMT $7.98
- DIN $29.62
- Resistance Level
- FDMT $8.74
- DIN $37.44
- Average True Range (ATR)
- FDMT 0.44
- DIN 1.35
- MACD
- FDMT 0.21
- DIN 0.52
- Stochastic Oscillator
- FDMT 38.78
- DIN 66.71
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations, and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.